BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22236254)

  • 1. Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy.
    Kubo T; Takei Y; Mihara K; Yanagihara K; Seyama T
    Bioconjug Chem; 2012 Feb; 23(2):164-73. PubMed ID: 22236254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
    Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.
    Kubo T; Yanagihara K; Sato Y; Nishimura Y; Kondo S; Seyama T
    Bioconjug Chem; 2013 Dec; 24(12):2045-57. PubMed ID: 24274056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-conjugated 27-nucleotide double-stranded RNAs with dicer-substrate potency enhance RNAi-mediated gene silencing.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Mol Pharm; 2012 May; 9(5):1374-83. PubMed ID: 22494497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicer-labile PEG conjugates for siRNA delivery.
    Kow SC; McCarroll J; Valade D; Boyer C; Dwarte T; Davis TP; Kavallaris M; Bulmus V
    Biomacromolecules; 2011 Dec; 12(12):4301-10. PubMed ID: 22053777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model.
    Kubo T; Yanagihara K; Seyama T
    Chem Biol Drug Des; 2016 Jun; 87(6):811-23. PubMed ID: 26800111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Dicer Knockout on RNA Interference Using Various Dicer Substrate Small Interfering RNA (DsiRNA) Structures.
    Song MS; Alluin J; Rossi JJ
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically modified symmetric and asymmetric duplex RNAs: an enhanced stability to nuclease degradation and gene silencing effect.
    Kubo T; Zhelev Z; Ohba H; Bakalova R
    Biochem Biophys Res Commun; 2008 Jan; 365(1):54-61. PubMed ID: 17971296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of gene silencing effect and membrane permeability by Peptide-conjugated 27-nucleotide small interfering RNA.
    Kubo T; Yanagihara K; Sato Y; Morita Y; Seyama T
    Molecules; 2012 Sep; 17(9):11089-102. PubMed ID: 22983148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of palmitic acid-conjugated DsiRNA for colon cancer in a mouse subcutaneous tumor model.
    Kubo T; Nishimura Y; Hatori Y; Akagi R; Mihara K; Yanagihara K; Seyama T
    Chem Biol Drug Des; 2019 Apr; 93(4):570-581. PubMed ID: 30560565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Dicer enhances RNAi-mediated gene silencing by short-hairpin RNAs (shRNAs) in human cells.
    Mikuma T; Kawasaki H; Yamamoto Y; Taira K
    Nucleic Acids Symp Ser (Oxf); 2004; (48):191-2. PubMed ID: 17150543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo.
    Foster DJ; Barros S; Duncan R; Shaikh S; Cantley W; Dell A; Bulgakova E; O'Shea J; Taneja N; Kuchimanchi S; Sherrill CB; Akinc A; Hinkle G; Seila White AC; Pang B; Charisse K; Meyers R; Manoharan M; Elbashir SM
    RNA; 2012 Mar; 18(3):557-68. PubMed ID: 22294662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference in vitro and in vivo using DsiRNA targeting the nucleocapsid N mRNA of human metapneumovirus.
    Darniot M; Schildgen V; Schildgen O; Sproat B; Kleines M; Ditt V; Pitoiset C; Pothier P; Manoha C
    Antiviral Res; 2012 Mar; 93(3):364-73. PubMed ID: 22285728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of gene silencing potency and nuclease stability by chemically modified duplex RNA.
    Kubo T; Zhelev Z; Bakalova R; Ohba H
    Nucleic Acids Symp Ser (Oxf); 2007; (51):407-8. PubMed ID: 18029759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development.
    Bégin-Lavallée V; Midavaine É; Dansereau MA; Tétreault P; Longpré JM; Jacobi AM; Rose SD; Behlke MA; Beaudet N; Sarret P
    Mol Pain; 2016; 12():. PubMed ID: 27306408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
    Ueno Y; Kawada K; Shibata A; Yoshikawa K; Wataya Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2008; (52):503-4. PubMed ID: 18776474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species specific inhibition of viral replication using dicer substrate siRNAs (DsiRNAs) targeting the viral nucleoprotein of the fish pathogenic rhabdovirus viral hemorrhagic septicemia virus (VHSV).
    Bohle H; Lorenzen N; Schyth BD
    Antiviral Res; 2011 Jun; 90(3):187-94. PubMed ID: 21439327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of modification pattern-RNAi activity relationships by using siRNAs modified with 4'-thioribonucleosides.
    Hoshika S; Minakawa N; Shionoya A; Imada K; Ogawa N; Matsuda A
    Chembiochem; 2007 Nov; 8(17):2133-8. PubMed ID: 17924376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.